Filing Flows › Comparisons › LAB vs ADCT
Standard Biotools vs ADC Therapeutics SA: LAB and ADCT compared
Standard Biotools is the larger company: $19.4M of revenue in its latest quarter (Q3 2026) against $19.2M for ADC Therapeutics SA (Q2 2026). ADC Therapeutics SA is growing faster (+2% against -0.9% a year earlier). Standard Biotools is more profitable, with an operating margin of -102.0% against -132.0%.
Where the money goes: LAB and ADCT
Standard Biotools (LAB) · Q3 2026
Standard Biotools, Q3 2026: revenue $19.4M (-0.9% year over year), operating margin -102.0%, net earnings $13.5M, operating cash flow −$6.2M. The chart follows the revenue to costs, profit and cash.
ADC Therapeutics SA (ADCT) · Q2 2026
ADC Therapeutics SA, Q2 2026: revenue $19.2M (+2% year over year), operating margin -132.0%, net loss $16.6M, operating cash flow −$11.8M. The chart follows the revenue to costs, profit and cash.
| Standard Biotools (LAB) | ADC Therapeutics SA (ADCT) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q2 2026 |
| Revenue | $19.4M | $19.2M |
| Revenue growth, Y/Y | -0.9% | +2% |
| Operating margin | -102.0% | -132.0% |
| Net earnings | $13.5M | −$16.6M |
| Net margin | 69.6% | -86.1% |
| Operating cash flow | −$6.2M | −$11.8M |
Where the revenue comes from
Standard Biotools
- Product: $14.3M (74%)
- Services and Other Revenue: $5.1M (26%)
ADC Therapeutics SA
- Product revenues, net: $18.6M (97%)
- Royalties: $614K (3%)
Questions
Which is bigger, Standard Biotools or ADC Therapeutics SA?
Standard Biotools is the larger company: $19.4M of revenue in its latest quarter (Q3 2026) against $19.2M for ADC Therapeutics SA (Q2 2026).
Is Standard Biotools or ADC Therapeutics SA growing faster?
ADC Therapeutics SA is growing faster (+2% against -0.9% a year earlier).
Which is more profitable, Standard Biotools or ADC Therapeutics SA?
Standard Biotools is more profitable, with an operating margin of -102.0% against -132.0%.
More: Standard Biotools earnings · how Standard Biotools makes money · ADC Therapeutics SA earnings · how ADC Therapeutics SA makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 3, 2026; 10-Q filed Aug 13, 2026). Fiscal quarters can end on different dates. Not investment advice.